Entering text into the input field will update the search result below

Rhythm Pharmaceuticals GAAP EPS of -$0.85 beats by $0.06, revenue of $1.82M beats by $0.12M

Mar. 01, 2022 7:14 AM ETRhythm Pharmaceuticals, Inc. (RYTM)By: Pranav Ghumatkar, SA News Editor
  • Rhythm Pharmaceuticals press release (NASDAQ:RYTM): Q4 GAAP EPS of -$0.85 beats by $0.06.
  • Revenue of $1.82M beats by $0.12M.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.